Relying on the strong research and development advantages of its parent company Senkicel, and combining advanced production equipment and technologies, Kazor Biotechnology has rapidly translated its R&D achievements into high-performance cell culture medium products for the market.

The company operates three major technology platforms: a cell quality control platform, a cell production and storage platform, and a cell application translation platform. Equipped with various inspection and testing equipment, we have built a B-grade cell preparation and storage platform that GMP requirements. We can provide various technical services such as stem cell, adult cell, and immune cell extraction, amplification, preparation, and storage for scientific research institutions, hospitals, pharmaceutical companies, and other customers. In the clinical application field of stem cells and immune cells, the company is actively expanding its research and development pipeline, while developing the application technology of extracellular vesicles in the field of skin repair.

The company is committed to cutting-edge life science research and technological innovation, and through a refined scientific research system and interdisciplinary collaboration, promotes the full chain development from basic research to clinical applications, and drives the transformation and industrialization of scientific research achievements.